Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIPROCOL: Diprosone for Prevention of EGFR Inhibitor-Induced Folliculitis
NCT00910676Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Oct 2007
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of betamethasone dipropionate in folliculitis, sponsored by Centre Oscar Lambret. Primary endpoint: Frequency of folliculitis at 8 weeks. Started Oct 2007; status: completed.
02
Drugs
betamethasone dipropionate
03
Conditions
folliculitis
Beyond the preview
Go deeper on NCT00910676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910676.